| Net Cash Provided by (Used in) Operating Activities |
$90,643,000 |
USD |
-361% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$89,438,000 |
USD |
907% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,205,000 |
USD |
89% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$47,721,000 |
USD |
67% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$11,827,000 |
USD |
1103% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$617,331,000 |
USD |
138% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$39,820,000 |
USD |
164% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |